Analyst Ratings for Jazz Pharmaceuticals PLC (JAZZ)

Updated: 2017-07-27

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) have received a consensus rating of Buy from Wall Street analysts. Last month, JAZZ received an average rating of Buy.

A buy rating was issued by 15 analysts, 0 gave an overweight rating, 3 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for JAZZ. The highest price target was 210, implying a possible profit of 32.38 percent. The lowest price target was 144, which equates to a potential downside of -9.23 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -4.87 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.05 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -2.47 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

JAZZ has an estimated earnings growth rate of 9.61 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. JAZZ has a PEG ratio of 2.53.

JAZZ has a 52-week high of 163.75 and a 52-week low of 95.80. Today's price is 65.59 percent above the 52-week low, and below the high by 3.12 percent. JAZZ has a P/E ratio of 24.29. Investors typically compare the P/E ratio to a company's peers in the industry. The JAZZ value stock report compares JAZZ to some of its peers using value stock charts. The stock has a market capitalization of $9.71 billion. JAZZ will post this quarters earnings in days, on 0000-00-00.